TE_26317
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSp |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.05 |
| Counts of samples | TCGA_tumor:76; TCGA_normal:58; GTEx:1782 |
| TSS | chr12(+):108796845 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_26317.1 | - | Intergenic | Non-coding | Non-coding | chr12(+):108796846,108797107,108797540,108797560 |
| teRNA_26317.2 | - | Intergenic | Non-coding | Non-coding | chr12(+):108796846,108797107,108811812,108811832 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
